Join Ahmed Obeidat, MD, PhD; Mitchell Freedman, MD; and Suma Shah, MD, for the second program of this monthly series as they discuss the evolution of therapeutics for the treatment of multiple sclerosis.
Mitchell Freedman, MD
Advertisement
Adjunct professor of neurology, University of North Carolina School of Medicine
Articles by Mitchell Freedman, MD
Advertisement
Latest Updated Articles
The Ever-Expanding Multiple Sclerosis TherapeuticsPublished: May 20th 2021 | Updated:
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Alexander Gold, MD, on Adrabetadex’s Impact in Infantile-Onset Niemann-Pick C
2
NeurologyLive® Brain Games: November 2, 2025
3
Showcasing Sustained Benefits in Myasthenia Gravis Research at AANEM 2025: Kimberly Moran, PhD, MBA
4
Designing the Phase 3 EMPEROR Trial and Future Considerations
5
